An oral medication shows benefits treating Type 1 diabetes for at least two years after diagnosis
Why are COVID vaccination rates still low in some countries?
3 March 2022Report recommends new screenings for lung and prostate cancers and improvements for existing programs
3 March 2022An oral medication shows benefits treating Type 1 diabetes for at least two years after diagnosis
Use of the drug verapamil to treat Type 1 diabetes continues to show benefits lasting at least two years, researchers report in the journal Nature Communications. Patients taking the oral blood pressure medication not only required less daily insulin two years after first diagnosis of the disease, but also showed evidence of surprising immunomodulatory benefits.
